India

(Reuters) - Nearly a dozen countries resumed use of AstraZeneca’s COVID-19 shots on Friday as EU and British regulators said its benefits outweighed any risks. Reports of rare instances of blood clotting had temporarily halted inoculations.

Country / Region Tags:

Africa

Australia

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about OVERVIEW: COVID-19 International briefs
Log in or register to post comments

More governments are setting up own vaccine production facilities to reduce dependence on foreign suppliers

Fri, 2021-03-12 19:41 — mike kraft

As vaccine nationalism deepens, governments pay to bring production home In the German town of Dessau, one of the sites of the Bauhaus art school, an institute was set up in 1921 to mass-produce vaccines that later helped strengthen the German Democratic Republic. Exactly 100 years later, the site is gearing up to be a one-stop shop to produce... Caroline Copley, Andreas Rinke, Allison Martell U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

India's vaccine approved for regular emergency use after Phase 3 trials show 81% efficacy

Fri, 2021-03-12 09:31 — mike kraft

India's vaccine approved for regular emergency use after Phase 3 trials show 81% efficacy India’s locally developed vaccine, Covaxin, has been given the same emergency use licensure as the Oxford-AstraZeneca vaccine, the country's Health Ministry announced Thursday. By <a href="/profiles/jessie-yeung">Jessie Yeung</a>, Melissa Macaya and <a href="/profiles/meg-wagner">Meg Wagner</a>, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about India's vaccine approved for regular emergency use after Phase 3 trials show 81% efficacy
Log in or register to post comments

OVERVIEW: Europe, Asia, Latin American developments

Mon, 2021-03-01 11:07 — mike kraft

Factbox: Latest on the worldwide spread of the coronavirus Johnson & Johnson's newly authorized vaccine has started shipping, while a highly transmissible variant of coronavirus first identified in the Brazilian city of Manaus has been detected in Britain for the first time. Reuters Staff U.S.

(Reuters) - World Bank President David Malpass urged countries to enter contracts for vaccines now so they could get delivery schedules, saying it was vital to get started in more countries and work through more channels.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about OVERVIEW: Europe, Asia, Latin American developments
Log in or register to post comments

WHO release on beginning of COVAX vaccine shipments

Fri, 2021-02-26 12:15 — mike kraft

COVID-19 vaccine doses shipped by the COVAX Facility head to Ghana, marking beginning of global rollout COVAX announces 600,000 doses of the AstraZeneca/Oxford vaccine licensed to Serum Institute of India have arrived in Accra, Ghana

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about WHO release on beginning of COVAX vaccine shipments
Log in or register to post comments

OVERVIEW: Europe, Africa Developments--Reuters

Fri, 2021-02-26 10:37 — mike kraft

Factbox: Latest on the worldwide spread of the coronavirus European Union leaders will meet on Thursday to try to speed up the production and rollout of vaccines in a race against the emergence of new variants that some fear could bring a third wave of the pandemic across the continent. Reuters Staff U.S.

* The World Health Organization is working with the European Commission to coordinate vaccine donations for other countries on the continent, the head of its European office said.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about OVERVIEW: Europe, Africa Developments--Reuters
Log in or register to post comments

WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use

Tue, 2021-02-16 22:47 — mike kraft

WHO lists two additional COVID-19 vaccines for emergency use and COVAX roll-out Today WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be rolled out globally through COVAX.

WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be rolled out globally through COVAX. The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use
Log in or register to post comments

Covid-19 Vaccines have become a diplomacy tool in third world

Fri, 2021-02-12 12:37 — mike kraft

NEW DELHI — India, the unmatched vaccine manufacturing power, is giving away millions of doses to neighbors friendly and estranged. It is trying to counter China, which has made doling out shots a central plank of its foreign relations. And the United Arab Emirates, drawing on its oil riches, is buying jabs on behalf of its allies.

The coronavirus vaccine — one of the world’s most in-demand commodities — has become a new currency for international diplomacy.

Country / Region Tags:

General Topic Tags: